Developing country vaccine industry constituency

in page functions

Gavi assigns one seat on its Board to a developing country pharmaceutical industry

The developing country pharmaceutical industry seat on the Gavi Board is currently held by Serum Institute of India Ltd and PT Bio Farma, members of the Developing Countries Vaccine Manufacturing Network  

Adar Poonawalla (Representative) and Juliman Fuad (Alternate) represent these manufacturers:

Nominations process  

The selection process is fully managed by the Developing Country Vaccine Manufacturers Network (DCVMN), a voluntary alliance of state-owned and private companies, which submits its candidates to the Governance Committee. Currently, the Board member and alternate are from different companies.

More on this topic


70% of cervical cancer cases can be prevented with human papillomavirus vaccines. One woman dies from cervical cancer every two minutes - or 275,000 a year - over 85% in the developing world.


More facts...

close icon

modal window here